Bridging the gap...
from research and discovery...
from research and discovery...
Discovery
Antibodies & tools for target & hit discovery
Preclinical Development
Assays & platforms for lead & process development
Clinical Development
Stratification and data management solutions
Market Approval
Solutions supporting product quality and efficacy
Screening
Screening tools for early detection
Diagnostics & Monitoring
End-to-end solutions for specialty diagnostics
to diagnostics and cure.
Latest news
Revvity announces FDA clearance for first automated free testosterone test
Read press releaseIndustries we serve
1.5K
new antibodies, kits, and reagents introduced annually for life science research.
peer-reviewed publications using our In Vivo imaging systems.
5,650
published citations of Dharmacon™ reagents in 2023.
94%
of the top 50 pharmaceutical companies worldwide use our innovative solutions.
no-wash immunoassays and reagents for efficient screening.
2M+
scientists across pharma, biotech, and academia utilize our software solutions.
licensees across Revvity's technology and licensing organization.
babies screened annually for life-threatening disorders with Revvity technologies.
blood samples analyzed with EUROIMMUN solutions to identify autoimmune disorders.
individuals tested for COVID-19 virus with Revvity tests.
individuals tested for latent TB infection with the T-SPOT.TB test since 2002.
Top 10
CROs use our reagents, instruments and software to support their clients in commercializing their discoveries.
Top 25
CDMOs utilize our proven life science technologies to support their clients in every part of their commercialization journey.
Revvity offers comprehensive life science solutions, technologies, and services, covering workflows from discovery to cure. We revolutionize biomedical research with a focus on translational multi-omics, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and more.
Collaborate with our skilled scientists and experts to reach your goals sooner. Our range of contract services supports preclinical oncology drug discovery, viral vector manufacture, omics discovery, the development of genetic disease treatments, and clinical genetic testing. We also provide novel licensable technologies for gene expression, editing, and delivery to help you bring safer, more effective treatments to patients.
Our innovative laboratory solutions enhance reproductive health across all stages. Our cutting-edge molecular solutions drive innovation in reproductive health science, while our advanced screening technologies enable early detection and timely interventions, ultimately empowering improved outcomes globally.
Our specialty portfolio delivers innovative, end-to-end solutions for identifying and investigating a broad range of immune system disorders. We integrate cutting-edge technologies, such as immunoassays, molecular assays, automation, and advanced software - to enable seamless workflow integration, ultimately expanding research and testing for these highly complex diseases.
Featured Blogs
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
Find your future at Revvity
Join Revvity's team of approximately 11,000 global colleagues and help us push boundaries in pursuit of better human health.
How can we help you?
We are here to answer your questions.